Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics and cardiovascular disease.

J K Allen1

  • 1Associate Professor, The Johns Hopkins University Schools of Nursing and Medicine, Baltimore, Maryland 21205, USA. jallen@son.jhmi.edu

The Nursing Clinics of North America
|August 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Report of Iris yellow spot virus on Onion in Canada.

Plant disease·2019
Same author

Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis.

Oncogene·2015
Same author

Identifying Feasible Design Concepts for Products with Competing Performance Requirements by Metamodeling of Loss-Scaled Principal Components.

Quality engineering·2012
Same author

Chronic low dose Adderall XR down-regulates cfos expression in infantile and prepubertal rat striatum and cortex.

Neuroscience·2010
Same author

Socioeconomic status is associated with frailty: the Women's Health and Aging Studies.

Journal of epidemiology and community health·2009
Same author

Allostatic load and frailty in the women's health and aging studies.

Biological research for nursing·2008
Same journal

Expecting the Unexpected.

The Nursing clinics of North America·2026
Same journal

Nursing at the Center of Emergencies.

The Nursing clinics of North America·2026
Same journal

A Scoping Review on Managing Mental Health Emergencies in Elderly Population in WHO Regions.

The Nursing clinics of North America·2026
Same journal

Support Strategies and Policy Recommendations to Manage the Aftermath of an Emergency or Traumatic Situation.

The Nursing clinics of North America·2026
Same journal

Navigating Extreme Weather Events: Experiences of Nursing Leaders in a Rural, Acute Care Hospital in Atlantic Canada.

The Nursing clinics of North America·2026
Same journal

Ensuring Patient-Centered Care During an Emergency in Resource-Constrained Primary Health Care Settings.

The Nursing clinics of North America·2026
See all related articles

Genetic factors significantly contribute to cardiovascular disease (CVD) risk beyond traditional factors. Understanding these genetic influences is crucial for developing new CVD therapies and treatments.

Area of Science:

  • Cardiovascular Genetics
  • Medical Genetics
  • Genomics

Background:

  • Traditional risk factors explain only about 50% of cardiovascular disease (CVD) variability.
  • A significant portion of CVD risk remains unexplained by conventional factors.
  • Genetic research is essential to understand the full spectrum of CVD risk.

Purpose of the Study:

  • To explore the genetic underpinnings of cardiovascular disease (CVD).
  • To detail genetic influences on established CVD risk factors.
  • To review genetic CVD disorders and emerging genetic therapies.

Main Methods:

  • Literature review of genetic influences on CVD risk factors.
  • Discussion of specific genetic cardiovascular disease disorders.
  • Highlighting advancements in genetic therapy for CVD.

Related Experiment Videos

Main Results:

  • Cardiovascular disease (CVD) can arise from single-gene mutations, combined mutations, or gene-environment interactions.
  • Genetic factors play a substantial role in the unexplained variance of CVD risk.
  • Genetic therapy shows promise for future CVD treatment strategies.

Conclusions:

  • Genetics is a critical determinant of cardiovascular disease (CVD) risk.
  • Further research into genetic CVD disorders and therapies is warranted.
  • Personalized medicine approaches incorporating genetic data may improve CVD prevention and treatment.